Estrada, N.; Zamora, L.; Ferrer-Marín, F.; Palomo, L.; García, O.; Vélez, P.; De la Fuente, I.; Sagüés, M.; Cabezón, M.; Cortés, M.;
et al. Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. J. Clin. Med. 2022, 11, 6217.
https://doi.org/10.3390/jcm11206217
AMA Style
Estrada N, Zamora L, Ferrer-Marín F, Palomo L, García O, Vélez P, De la Fuente I, Sagüés M, Cabezón M, Cortés M,
et al. Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. Journal of Clinical Medicine. 2022; 11(20):6217.
https://doi.org/10.3390/jcm11206217
Chicago/Turabian Style
Estrada, Natalia, Lurdes Zamora, Francisca Ferrer-Marín, Laura Palomo, Olga García, Patricia Vélez, Iris De la Fuente, Miguel Sagüés, Marta Cabezón, Montserrat Cortés,
and et al. 2022. "Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients" Journal of Clinical Medicine 11, no. 20: 6217.
https://doi.org/10.3390/jcm11206217
APA Style
Estrada, N., Zamora, L., Ferrer-Marín, F., Palomo, L., García, O., Vélez, P., De la Fuente, I., Sagüés, M., Cabezón, M., Cortés, M., Vallansot, R. O., Senín-Magán, M. A., Boqué, C., & Xicoy, B.
(2022). Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. Journal of Clinical Medicine, 11(20), 6217.
https://doi.org/10.3390/jcm11206217
